Hartley Rogers, chairman of Hamilton Lane, has guided the investment management firm into a global leader in private markets solutions. With decades of experience in private equity and alternative investments, he helped scale Hamilton Lane’s platform to manage and advise on hundreds of billions in assets for institutional clients worldwide. Known for his strategic leadership and deep industry expertise, Rogers has positioned the firm at the forefront of private markets investing, while also serving on boards and engaging in philanthropic initiatives.

Hamilton “Tony” James, veteran financier and former executive vice chairman of Blackstone, played a central role in building the firm into the world’s largest alternative asset manager. Joining Blackstone in 2002 after a long career at Donaldson, Lufkin & Jenrette and Credit Suisse, he helped drive its expansion across private equity, real estate, credit, and hedge fund solutions. Known for his strategic vision and operational discipline, James also became a trusted voice in public policy and philanthropy, cementing his reputation as one of Wall Street’s most influential dealmakers.

Hamdi Ulukaya, founder and CEO of Chobani, transformed the U.S. yogurt market by popularizing Greek yogurt and building a multibillion-dollar food company from humble beginnings. An immigrant from Turkey, he bought a shuttered Kraft plant in upstate New York in 2005 and grew Chobani into America’s top-selling yogurt brand through bold marketing, product innovation, and a commitment to quality. Known for his “anti-CEO” ethos, Ulukaya has championed employee ownership, progressive workplace policies, and refugee support initiatives, redefining what it means to build a purpose-driven business.

Gregg Hymowitz, founder, chairman, and CEO of EnTrust Global, has built one of the world’s leading alternative investment firms, managing billions across hedge funds, private equity, real assets, and impact investments. With a career spanning decades in finance, Hymowitz launched EnTrust in 1997 and later orchestrated its merger with Permal to expand global reach. Known for his innovative approach to portfolio construction and commitment to ESG strategies, he has positioned EnTrust Global as a trusted partner for institutional investors worldwide.

Greg Mondre, co-CEO of Silver Lake, is one of the most influential investors in technology private equity. Since joining the firm in 1999, he has played a central role in building it into a global powerhouse with over $100 billion in assets under management. Mondre has overseen landmark deals in companies such as Dell Technologies, Skype, and Twitter, cementing his reputation as a shrewd dealmaker with a deep understanding of the tech sector. His leadership continues to shape Silver Lake’s strategy at the forefront of high-growth, innovation-driven investments.

Glenn Dubin, billionaire hedge fund manager and philanthropist, cofounded Highbridge Capital Management in 1992, growing it into one of the world’s premier alternative investment firms before selling a majority stake to JPMorgan Chase in 2004. After leaving Highbridge, he launched Dubin & Co., a private investment firm with interests spanning energy, healthcare, and consumer businesses. Known for his disciplined approach to investing and extensive philanthropic commitments in health, education, and community development, Dubin has cemented his reputation as both a savvy financier and committed benefactor.

George Yancopoulos, cofounder, president, and chief scientific officer of Regeneron Pharmaceuticals, is one of the most accomplished scientist-executives in biotechnology. A Columbia-trained physician and molecular immunologist, he helped shape Regeneron’s R&D engine, leading to breakthrough therapies in ophthalmology, immunology, oncology, and infectious disease. Under his guidance, the company developed Eylea, a blockbuster treatment for macular degeneration, and partnered in creating COVID-19 antibody therapies. With hundreds of patents and a reputation for scientific rigor, Yancopoulos has become a driving force behind Regeneron’s rise as a global biotech leader.

O. Francis Biondi, cofounder of King Street Capital Management, launched the hedge fund in 1995 alongside fellow First Boston alum Brian Higgins, building it into a global powerhouse with over $25 billion in assets under management. Specializing in contrarian plays across stocks and bonds, the firm became a dominant force in distressed and value investing. Biondi retired in 2020 but retained his ownership stake, cementing his legacy as a shrewd investor and architect of one of the most respected names in alternative asset management.

Felix Baker is a highly influential biotech-focused investor and co-founder of Baker Brothers Advisors, a leading hedge fund specializing in healthcare and biotechnology investing. Through his firm, established in 2000, Felix manages over $20 billion in assets and helped generate an estimated $8 billion gain from early investments in Seagen. A PhD immunologist and Stanford alumnus, he also serves on boards of key biotech companies and contributes to Stanford’s biosciences initiatives.

Edward Scott “Eddie” Lampert is an American billionaire investor and founder of ESL Investments, established in 1988 after stints at Goldman Sachs and backing from Richard Rainwater. He famously orchestrated the merger of Kmart and Sears in 2005 and led Sears Holdings until 2019, after acquiring it via bankruptcy auction through Transformco. His record has been polarizing—praised for contrarian success at AutoZone and AutoNation, yet widely criticized for Sears’ collapse.

Douglas Leone is a billionaire venture capitalist and former Global Managing Partner at Sequoia Capital. Recruited in 1988, he rose to partner in 1993 and later led Sequoia’s international expansion across China, India, and Southeast Asia. Under his stewardship, Sequoia backed major tech wins including ServiceNow, RingCentral, Medallia, Nubank, and YouTube.

Devin Finzer is the American entrepreneur who co‑founded OpenSea in December 2017, becoming the largest global marketplace for NFTs. A Brown University alumnus in computer science and mathematics, he previously built Claimdog (acquired by Credit Karma) and worked at Pinterest, Flipboard, and Google on product growth. OpenSea’s rapid rise made him one of the first NFT billionaires in 2022, though its valuation has since declined amid market turbulence and regulatory pressures.

David Walentas is the self-made real estate developer behind Two Trees Management, the Brooklyn firm that transformed Dumbo and Williamsburg from industrial decline into high-end residential and creative districts. A University of Virginia alumnus, Walentas began with a small Manhattan partnership in 1968 and leveraged $12 million to acquire nearly 2 million sq ft in Dumbo, reshaping it through bold vision and rezoning advocacy.

David M. Siegel is an American computer scientist turned investor who co-founded Two Sigma Investments in 2001 alongside John Overdeck. With a PhD in Computer Science from MIT and early roles at D. E. Shaw and Tudor, Siegel helped build Two Sigma into a quant trading powerhouse managing roughly $60 billion in assets. He now serves as co-chairman and leads the firm’s technology and philanthropy initiatives through the Siegel Family Endowment.

David E. Shaw is the Stanford‑trained computer scientist turned Wall Street quant and billionaire founder of D. E. Shaw & Co.. Launched in 1988 with $28 million, the firm pioneered algorithmic trading and grew into one of the world’s largest hedge funds—managing ~$65 billion in assets by 2025. Shaw stepped back from daily operations in 2001 to lead D. E. Shaw Research, advancing computational biochemistry and molecular-dynamics simulations.

David Martínez Guzmán is a discreet billionaire investor and founder & managing partner of Fintech Advisory, a global advisory and debt investment firm based in New York and London. Known as one of the most influential Mexican financiers on Wall Street, Martínez led major restructurings of Argentina’s sovereign debt and controls sizable stakes in Telecom Argentina, Grupo Clarín, Grupo Televisa, and other Latin American assets. 

David Lichtenstein is a self-made real estate billionaire who founded The Lightstone Group in 1988. He began with a single multifamily unit and grew his firm into a diversified empire—owning 25,000 apartments and over 15 million sq ft of retail, industrial, hotel & life-sciences properties across 25+ states, with more than $9 billion in managed assets. He led major deals such as acquiring Prime Retail malls ($638 M) and Extended Stay Hotels ($8.1 B) and is active in civic service and board leadership across New York institutions. 

David Golub is the business leader heading Golub Capital, a top-tier direct lender he joined in 2003, and CEO of its NASDAQ‑listed Golub Capital BDC, managing over $75 billion in capital. A Harvard and Stanford MBA alumnus, he helped build Golub into a private-credit powerhouse and serves as longtime board chair of The Michael J. Fox Foundation.

David Geffen is an American entertainment mogul, record‑label founder, and philanthropist. He launched Asylum Records (1970), Geffen Records (1980), DGC Records (1990), and co‑founded DreamWorks SKG in 1994. His music and film empire helped define modern pop culture and Hollywood.

David Blitzer is an American investor and sports team owner. As Blackstone’s Chairman of Tactical Opportunities, he oversees global investing across asset classes. In 2011, he co-founded Harris Blitzer Sports & Entertainment (HBSE), the first entity to hold equity in all five major U.S. men’s leagues (NBA, NHL, NFL, MLB, MLS). His portfolio includes the Philadelphia 76ers, New Jersey Devils, Cleveland Guardians, Real Salt Lake (now minority stake), and the Washington Commanders.